niceritrol has been researched along with probucol in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Itakura, H | 1 |
Mimura, K; Yukawa, S | 1 |
Fukushima, N; Ozaki, I; Sakai, T; Setoguchi, Y; Yamamoto, K; Yanagita, T | 1 |
Cziraky, MJ; Spinler, SA | 1 |
Hotta, O; Ieiri, N; Taguma, Y | 1 |
1 review(s) available for niceritrol and probucol
Article | Year |
---|---|
Lipoprotein(A): physiologic function, association with atherosclerosis, and effects of lipid-lowering drug therapy.
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Clinical Trials as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoprotein(a); Lipoproteins, LDL; Liver; Niacin; Niceritrol; Probucol; Randomized Controlled Trials as Topic | 1994 |
5 other study(ies) available for niceritrol and probucol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Treatment of hyperlipidemia].
Topics: Blood Component Removal; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Dietary Fiber; Energy Intake; Female; Humans; Hyperlipidemias; Male; Niceritrol; Pravastatin; Probucol | 1992 |
[Hyperlipidemia and drug treatment].
Topics: Arteriosclerosis; Carnitine; Cholestyramine Resin; Glomerulonephritis; Humans; Hyperlipidemias; Kidney Failure, Chronic; Niceritrol; Pantetheine; Pravastatin; Probucol; Vitamin E | 1991 |
New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia.
Topics: Adult; Aged; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Niceritrol; Patient Compliance; Probucol; Triglycerides | 1991 |
Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy.
Topics: Adult; Anticholesteremic Agents; Apolipoproteins E; Drug Combinations; Eicosapentaenoic Acid; Female; Fenofibrate; Humans; Hypolipidemic Agents; Kidney Diseases; Kidney Glomerulus; Lipids; Lipoproteins; Male; Microscopy, Electron; Nephrotic Syndrome; Niceritrol; Pedigree; Probucol | 2003 |